Renal insufficiency
Chronic renal failure (CRF) refers to a slowly progressive renal impairment caused by various kidney diseases, which eventually leads to uremia and complete loss of renal function, causing a series of clinical symptoms and a clinical syndrome consisting of biochemical, endocrine and other metabolic disorders. The interval from the onset of the primary disease to the onset of renal insufficiency can be several years to more than ten years. Chronic renal failure is a serious stage of renal insufficiency.
Related Drugs
Recombinant human growth hormone for injection
Indication: It is used for growth hormone deficiency in children and adults, Turner's syndrome, growth failure caused by chronic renal failure in children, hypermetabolic state (negative nitrogen balance) after surgery and trauma, burns, and sepsis.
Recombinant human growth hormone for injection
Indication: It is used for growth hormone deficiency in children and adults, Turner's syndrome, growth failure caused by chronic renal failure in children, hypermetabolic state (negative nitrogen balance) after surgery and trauma, burns, and sepsis.
Calcium polystyrene sulfonate powder
Indication: It is used as a clinical auxiliary treatment drug for acute and chronic renal insufficiency and renal failure, especially for hyperkalemia caused by nephritis, renal failure, major surgical operation, trauma, crush injury, burns, severe infection, massive blood loss, etc.
Calcium polystyrene sulfonate powder
Indication: Potassium-lowering drugs are mainly used to prevent and treat hyperkalemia in patients with acute and chronic renal insufficiency and renal failure.
Recombinant human erythropoietin-β injection
Indication: Rocoman is suitable for dialysis patients with anemia caused by chronic renal failure. Rocoman is suitable for the treatment of pathological renal anemia in patients with non-dialysis renal insufficiency.